P. Thebault et al. / Journal of Fluorine Chemistry 128 (2007) 211–218
217
N(CH3)2); 2.35 (2H, m, CH2 N(CH3)2); 2.4–2.6 (4H, m,
CF2CH2CH2); 3.15 (2H, t, J = 7 Hz, NHCH2). 19F NMR
(MeOD) d: ꢀ82.5 (3F, CF3); ꢀ116 (2F, CF2CH2); ꢀ125 (2F,
CF3CF2CF2); ꢀ127.5 (2F, CF3CF2).
1H NMR (MeOD) d: 1.65 (2H, m, NHCH2CH2); 2.2 (6H, s,
N(CH3)2); 2.35 (2H, m, CH2N(CH3)2); 2.4–2.6 (4H, m,
CF2CH2CH2); 3.15 (2H, t, J = 7 Hz, NHCH2). 19F NMR
(MeOD) d: ꢀ82.5(3F, CF3); ꢀ116 (2F, CF2CH2); ꢀ125 (2F,
CF3CF2CF2); ꢀ127.5 (2F, CF3CF2).
CF2CH2CH2); 2.85 (2H, m, CH2SO3ꢀ); 3.05 (6H, s,
N+(CH3)2); 3.3–3.6 (6H, m, NHCH2CH2N+(CH3)2CH2). 19F
NMR (MeOD) d: ꢀ82.5 (3F, CF3); ꢀ116 (2F, CF2CH2); ꢀ123
(2F, CF2CF2CH2); ꢀ124 (2F, CF2CF2CF2CH2); ꢀ125 (2F,
CF3CF2CF2); ꢀ127.5 (2F, CF3CF2); 13C NMR (MeOD) d:
18.5(1C, s, CH2CH2SO3ꢀ); 22(1C, s, NHCH2CH2); (1C, s,
CH2SO3ꢀ); 26.5 (2C, m, CF2CH2CH2); 36 (1C, s, NHCH2);
47(1C, s, CH2SO3ꢀ); 50.5 (2C, s, N+(CH3)2); 62 (2C, m,
CH2N+(CH3)2CH2). This structure was also confirmed by the
2b—RF = C6F13; m = 2; bp (8C)/mmHg = 128/7.6 ꢂ 10ꢀ3
;
1
2D H NMR COSY spectrum. Mass spectrum (ESI+)—m/z:
2c—RF = C8F17; m = 2; bp (8C)/mmHg = 140/7.6 ꢂ 10ꢀ3
;
599.3 [M + H]+; 621 [M + Na]+; 1219.5 [2M + Na]+. HRMS:
(m/z) calcd for C17H23N2O4SF13 [M + H]+, 599.1242; found
599.1244.
1H NMR (MeOD) d: 1.65 (2H, m, NHCH2CH2); 2.2 (6H, s,
N(CH3)2); 2.35 (2H, m, CH2 N(CH3)2); 2.4–2.6 (4H, m,
CF2CH2CH2); 3.15 (2H, t, J = 7 Hz, NHCH2). 19F NMR
(MeOD) d: ꢀ82.5 (3F, CF3); ꢀ116 (2F, CF2CH2); ꢀ123 (2F,
(CF2)3CF2CH2); ꢀ124 (2F, CF2CF2CF2CH2); ꢀ125 (2F,
CF3CF2CF2); ꢀ127.5 (2F, CF3CF2).
3c—RF = C8F17; m = 2, refractive index = 1.4196; 1H NMR
(MeOD) d: 1.95 (2H, m, NHCH2CH2); 2.2 (2H, m,
CH2CH2SO3ꢀ); 2.5 (4H, m, CF2CH2CH2); 2.85 (2H, m,
CH2SO3ꢀ); 3.05 (6H, s, N+(CH3)2); 3.3–3.6 (6H, m, NHCH2,
CH2N+(CH3)2CH2). 19F NMR (MeOD) d: ꢀ82.5 (3F, CF3);
ꢀ116 (2F, CF2CH2); ꢀ123 (2F, (CF2)3CF2CH2); ꢀ124 (2F,
CF2CF2CF2CH2); ꢀ125 (2F, CF3CF2CF2); ꢀ127.5 (2F,
CF3CF2). 13C NMR (MeOD) d: 18.5(1C, s, CH2CH2SO3ꢀ);
22(1C, s, NHCH2CH2); 26.5 (2C, m, CF2CH2CH2); 36 (1C, s,
NHCH2); 47(1C, s, CH2SO3ꢀ); 50.5 (2C, s, N+(CH3)2); 62 (2C,
m, CH2N+(CH3)2CH2). This structure was also confirmed by
the 2D 1H NMR COSY spectrum. Mass spectrum (ESI+)—m/z:
699.3 [M + H]+. HRMS: (m/z) calcd for C19H23N2O4SF17
[M + H]+, 699.1179; found 699.1181.
2d—RF = C2F5; m = 10; bp (8C)/mmHg = 112/7.6 ꢂ 10ꢀ3
;
1H NMR (MeOD) d: 1.3 (12H, m, (CH2)6CH2C2H4CO); 1.5
(6H, m, RFCH2CH2(CH2)6CH2, NHCH2CH2); 2.2 (12H, m,
CF2CH2,CH2CO,CH2N(CH3)2); 3.2 (2H, m, NHCH2). 19F
NMR (MeOD) d: ꢀ88.5 (3F, CF3); ꢀ121 (2F, CF2CH2)
2e—RF = C4F9; m = 10; m.p. = 40–41 8C; 1H NMR
(MeOD) d: 1.3 (12H, m, (CH2)6CH2C2H4CO); 1.5 (6H, m,
RFCH2CH2(CH2)6CH2, NHCH2CH2); 2.2 (12H, m, CF2CH2,
CH2CO,CH2N(CH3)2); 3.2 (2H, m, NHCH2). 19F NMR
(MeOD) d: ꢀ84.5 (3F, CF3); ꢀ118 (2F, CF2CH2); ꢀ128.5
(2F, CF2CF2CH2); ꢀ129.5 (2F, CF3CF2).
3d—RF = C2F5; m = 10; bp (8C)/mmHg = 160/7.6 ꢂ 10ꢀ3
;
refractive index = 1.4280; 1H NMR (MeOD) d: 1.3 (12H,
m,(CH2)6CH2C2H4CO); 1.6 (4H, m, RFCH2CH2(CH2)6CH2);
1.95 (2H, m, NHCH2CH2); 2.2 (6H, m, CF2CH2,CH2
CO,CH2CH2SO3ꢀ); 2.85 (2H, m, CH2SO3ꢀ); 3.05 (6H, s,
N+(CH3)2); 3.3–3.5 (6H, m, NHCH2,CH2N+(CH3)2CH2). 19F
NMR (MeOD) d: ꢀ88.5 (3F, CF3); ꢀ121 (2F, CF2CH2); 13C
NMR (MeOD) d: 18.5 (1C, s, CH2CH2SO3ꢀ); 20 (1C, s,
CF2CH2CH2); 22(1C, s, NHCH2CH2); 25 (1C, s, CH2CH2CO);
28 (6C, s, CH2(CH2)6CH2); 29,5 (1C, m, CF2CH2); 36 (2C, s,
CH2CONHCH2); 47 (1C, s, CH2SO3ꢀ); 50.5 (2C, s, N+(CH3)2);
62 (2C, m, CH2N+(CH3)2CH2). This structure was also
confirmed by the 2D 1H NMR COSY spectrum. Mass spectrum
(ESI+)—m/z: 511.4 [M + H]+; 533.4 [M + Na]+; 1043.7
[2M + Na]+; HRMS: (m/z) calcd for C21H39N2O4SF5
[M + H]+, 511,2623; found 511,2624.
4.6. Synthesis of surfactants (3a–e)
A mixture of 2 ꢂ 10ꢀ3 mole of the amide previously
prepared and 5 ꢂ 10ꢀ3 mole of propanesultone was added to
20 mL of a mixture of diethyl ether/acetonitrile (2/1). The
reaction was stirred and heated at 50 8C for 24 h.
White precipitates were filtered and washed with acetone
several times. FASB-2.10 was also purified by column
chromatography over silica gel using methanol as the eluant.
The surfactants were obtained in 49–66% yield as oils,
excepted for FASB-4,2 which was obtained as white powder
and FASB-2,10 as colourless liquid.
3a—RF = C4F9; m = 2; m.p. = 108–109 8C; 1H NMR
(MeOD) d: 1.9 (2H, m, NHCH2CH2); 2.2 (2H, m,
CH2CH2SO3ꢀ); 2.5 (4H, m, CF2CH2CH2); 2.85 (2H, m,
CH2SO3ꢀ); 3.05 (6H, s, N+(CH3)2); 3.3–3.6 (6H, m,
NHCH2,CH2N+(CH3)2CH2); 19F NMR (MeOD) d: ꢀ82.5
(3F, CF3); ꢀ116 (2F, CF2CH2); ꢀ125 (2F, CF3CF2CF2);
ꢀ127.5 (2F, CF3CF2). 13C NMR (MeOD) d: 18.5(1C, s,
CH2CH2SO3ꢀ); 22(1C, s, NHCH2CH2); 26.5 (2C, m,
CF2CH2CH2); 36 (1C, s, NHCH2); 47(1C, s, CH2SO3ꢀ);
50.5 (2C, s, N+(CH3)2); 62 (2C, m, CH2N+(CH3)2CH2). This
structure was also confirmed by the 2D 1H NMR COSY
spectrum. Mass spectrum (ESI+)—m/z: 499.3 [M + H]+; 521.3
[M + Na]+. HRMS: (m/z) calcd for C15H23N2O4SF9 [M + H]+,
499.1307; found 499.1308.
3e—RF = C4F9; m = 10; refractive index = 1.4430; 1H NMR
(MeOD) d: 1.3 (12H, m,(CH2)6CH2C2H4CO); 1.6 (4H, m,
RFCH2CH2(CH2)6CH2); 1.95 (2H, m, NHCH2CH2); 2.2 (6H,
m, CF2CH2,CH2CO,CH2CH2SO3ꢀ); 2.85 (2H, m, CH2SO3ꢀ);
3.05 (6H, s, N+(CH3)2); 3.3-3.5 (6H, m, NHCH2,
CH2N+(CH3)2CH2; 19F NMR (MeOD) d: ꢀ84.5 (3F,
CF3,3F); ꢀ118 (2F, CF2CH2); ꢀ128.5 (2F, CF2CF2CH2);
ꢀ129.5 (2F, CF3CF2); 13C NMR (MeOD) d: 18.5 (1C, s,
CH2CH2SO3ꢀ); 20 (1C, s, CF2CH2CH2); 22(1C, s, NHCH2
CH2); 25 (1C, s, CH2CH2CO); 28 (6C, s, CH2(CH2)6CH2); 29,5
(1C, m, CF2CH2); 36 (2C, s, CH2CONHCH2); 47 (1C, s,
CH2SO3ꢀ); 50.5 (2C, s, N+(CH3)2); 62 (2C, m, CH2N+(CH3)2
1
1
3b—RF = C6F13; m = 2; H NMR (MeOD) d: 1.95 (2H, m,
CH2). This structure was also confirmed by the 2D H NMR
COSY spectrum. Mass spectrum (ESI+)—m/z: 611.4 [M + H]+;
NHCH2CH2); 2.2 (2H, m, CH2CH2SO3ꢀ); 2.5 (4H, m,